Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Endometrial Neoplasms × LY 353381 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Medroxyprogesterone Acetate 2 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 fluciclovine F-18 1 ferrous gluconate 1 dostarlimab 1 Watchful Waiting 1 Sunitinib 1 Specimen Handling 1 Observation 1 Metformin 1 LY 353381 1 Indocyanine Green 1 High-Energy Shock Waves 1 Biomarkers 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00190697 2007-05-25

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Eli Lilly and Company

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡